NCL

Research News

Scientists develop indigenous nasopharyngeal swabs

New Delhi, 06 June (India Science Wire): In the current pandemic scenario, global supplies of nasopharyngeal (NP) swabs are not dependable resulting in supply chain delays, escalating prices and variable quality. CSIR-National Chemical Laboratory (CSIR-NCL), Pune, has developed an indigenous NP swab for collecting samples from the throat cavity of COVID-19 patients. The need for making available domestic technology for NP swabs was flagged by CSIR to NCL in mid-April. Nasopharyngeal swab is a medical device with stringent specifications of quality, polymer grade, dimensions and sterilization. An NP swab consists of a cylindrical plastic stick with a brush-like tip of synthetic bristles/flocks. The flocking process helps align the fine bristles in a parallel orientation on the stick head, much like a toothbrush, except that this has round uniform geometry and the NP swab bristles are of micron diameter. The NCL team of polymer science and chemical engineering scientists – which included Dr. Chandrashekhar V. Rode, Dr. Prakash P. Wadgaonkar, and Dr. Anuya A. Nisal  – successfully worked out the detailed specifications of NP swab polymers and adhesives. The specifications included medical-grade materials that must be used for manufacture, the swab design and the packaging and sterilization protocols. “This is an excellent example of optimizing the polymer specifications and validating the chemical analysis of an urgently needed medical swab product in a very short time,” noted Dr. Ashwini Kumar Nangia, Director, NCL. The NCL has transferred the process knowhow of indigenous NP swabs for sample collection to a Mumbai-based chemical company under the COVID-19 technology transfer guidelines of CSIR. After confirming the correct chemical and polymer composition of NP swabs, their diameter, alignment of bristles, and sterilization method, NCL has suggested the next regulatory pathway for approval of medical devices to the company. They will be able to produce 1 lakh NP swabs per day.


Kidney Disease

Researchers identify biomarker for early prediction of diabetic kidney failure

Urine based biomarker for early prediction of diabetic kidney failure identified New Delhi, February 21: Diabetic Kidney failure or Diabetic Nephropathy is among the most significant longer-term complications associated with type 2 diabetes. The risk of End-Stage Renal Disease (ESRD) and resulting premature disease and death is estimated to increase by 12-fold with diabetes. A group of researchers from various institutions have identified urine based biomarker for early prediction of diabetic kidney failure. The biomarker, Microalbuminuria (MIC) is an early non-invasive marker of kidney disease and its progression. However, it takes several years of diabetes for MIC to occur. Interventions are also much less effective in some patients with MIC who manifest advanced pathological changes. Development of sensitive early stage disease markers and alternative diagnostic approaches may help in early detection of diabetic kidney failure. “This new study is significant because the findings should cause concern in a country where most treatment costs are paid out-of-pocket by patients, and highlight the urgent need for early diagnosis, effective prevention measures and search for novel therapeutic measures” Dr Kuppan Gokulakrishnan, Assistant Professor, Department of Neurochemistry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore . Symmetric and asymmetric dimethylarginines (SDMA and ADMA) are structural isomers. Altered circulatory asymmetric and symmetric dimethylarginines have been independently reported in patients with end-stage renal failure suggesting their potential role as mediators and early biomarkers of nephropathy. These alterations can also be reflected in the urine. “There are isomers found in every human but in nephropathy patients it suddenly goes out of range. The drop is indicative that there is a disease possibility. We looked at ratio of these isomers that gave us the diagnostic properties” said Dr Venkateswarlu Panchagnula, lead researcher, National Chemical Laboratory (NCL), Pune. The researchers evaluated the efficiency of Asymmetric to Symmetric dimethylarginine Ratio (ASR) using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI MS) from more than 500 people with varying levels of glucose intolerance as well as in patients with type 2 diabetes with or without diabetic kidney disease. The study found that the ASR profile is lower in MIC and macroalbuminuria (MAC)…